Compare Mutual Funds
Select a Mutual Fund
Risk
Very High
-
Rating
5.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.86
-
NAV
₹37.96
-
Fund Started
25 Jun 2018
-
Fund Size
₹6658.41 Cr
-
Exit Load
Exit load of 1% if redeemed within 15 days.
-
1 Year
8.03%
-
3 Year
27.09%
-
5 Year
16.93%
-
Equity
97.60%
-
Cash
2.37%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
-
Launch Date
25 Jun 2018
-
